Development of a novel safety assessment method for quality control of mRNA vaccines based on lung biomarker gene expression. Hiraga K, Momose H, Kuribayashi W, Uemura M, et al. Vaccine 2025;65:127805.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hiraga K, Momose H, Kuribayashi W, Uemura M, et al. Development of a novel safety assessment method for quality control of mRNA vaccines based on lung biomarker gene expression. Vaccine 2025;65:127805.
PMID: 41046838